REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,285,736 | -90.8% | 123,821 | -86.5% | 0.02% | -92.3% |
| Q3 2022 | $24,793,000 | +2723.8% | 918,275 | +1345.6% | 0.20% | +2700.0% |
| Q2 2022 | $878,000 | -32.3% | 63,520 | -4.4% | 0.01% | -22.2% |
| Q1 2022 | $1,296,000 | -66.3% | 66,451 | -71.8% | 0.01% | -65.4% |
| Q4 2021 | $3,844,000 | +263.3% | 235,524 | +261.4% | 0.03% | +160.0% |
| Q4 2019 | $1,058,000 | -67.1% | 65,176 | -73.6% | 0.01% | -74.4% |
| Q3 2019 | $3,215,000 | +3.8% | 247,291 | +3.5% | 0.04% | -9.3% |
| Q2 2019 | $3,098,000 | +343.2% | 238,847 | +364.7% | 0.04% | +207.1% |
| Q2 2016 | $699,000 | -51.7% | 51,400 | -38.0% | 0.01% | -54.8% |
| Q1 2016 | $1,447,000 | – | 82,890 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |